US FDA approves Lupin’s Mirabegron extended-release tablets EP News Bureau Sep 29, 2022 The product will be manufactured at Lupin’s facility in Nagpur
Less than five per cent of adults with overactive bladder currently treated with drug therapies:… EP News Bureau Jan 6, 2022 The company noted that despite this surprisingly low number and the clear need for new therapies, the late-stage pipeline is…